Cadila Healthcare’s arm receives final approval from USFDA for Clozapine Tablets

08 Dec 2017 Evaluate

Cadila Healthcare’s wholly owned subsidiary - Zydus Pharmaceuticals (USA) Inc., has received the final approval from the US Food and Drug Administration (USFDA) to market Clozapine Tablets in strengths of 25 mg, 50 mg, 100 mg, and 200 mg. The drug is used to treat schizophrenia. It will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad.

The group now has more than 175 approvals and has so far filed over 310 ANDAs since the commencement of the filing process in FY 2003-04.

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.


Zydus Lifesciences Share Price

931.45 -3.75 (-0.40%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×